Qureshi, Anila
University of Vienna · Memorial Sloan Kettering Cancer Center · Radboud University Nijmegen · Cornell University · Charles University · Université Paris-Saclay · Bristol-Myers Squibb (United States) · Hospital Universitario Virgen del Rocío · Weill Cornell Medicine · Technical University of Munich · Icahn School of Medicine at Mount Sinai
2 papers on CoChat
Most cited papers
- Verified
Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma
Weber, J., Mandala, M., Del Vecchio, M., Gogas, H. J., Arance, A. M., Cowey, C. L., Dalle, S., Schenker, M., Chiarion-Sileni, V., Marquez-Rodas, I., et al. (2017) · New England Journal of Medicine
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 2,246
- Verified
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
Bajorin, D. F., Witjes, J. A., Gschwend, J. E., Schenker, M., Valderrama, B. P., Tomita, Y., Bamias, A., Lebret, T., Shariat, S. F., Park, S. H., et al. (2021) · New England Journal of Medicine
Bladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers
Cited by 1,065
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free